Free tool
FAERS Monitor: Zinplava
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 761046 or its brand name (Zinplava, Bezlotoxumab). Reports on generic versions are filed under their own applications.
Reports
350
Serious
271
77% of reports
Hospitalization
109
Death reported
63
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- clostridium difficile infection129
- drug ineffective72
- treatment failure43
- diarrhoea29
- clostridium difficile colitis21
- death19
- pyrexia18
- nausea17
- clostridium test positive16
- product use in unapproved indication14
- adenovirus infection13
- avian influenza13
- klebsiella infection13
- renal graft infection13
- urinary tract infection pseudomonal13
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2017 | 23 |
| 2018 | 33 |
| 2019 | 59 |
| 2020 | 93 |
| 2021 | 36 |
| 2022 | 29 |
| 2023 | 36 |
| 2024 | 23 |
| 2025 | 12 |
| 2026 | 6 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,809 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| avian influenzaSignal | 13 | 15333.3 | 8416.1 | 146,840 |
| renal graft infectionSignal | 13 | 3570.8 | 2061.0 | 40,490 |
| urinary tract infection pseudomonalSignal | 13 | 1329.9 | 775.4 | 15,615 |
| clostridium test positiveSignal | 16 | 439.3 | 271.7 | 6,518 |
| clostridium difficile infectionSignal | 129 | 357.3 | 311.3 | 45,251 |
| adenovirus infectionSignal | 13 | 270.6 | 158.5 | 3,213 |
| klebsiella infectionSignal | 13 | 154.9 | 90.8 | 1,832 |
| clostridium difficile colitisSignal | 21 | 119.3 | 78.8 | 2,343 |
| treatment failureSignal | 43 | 31.2 | 23.6 | 1,231 |
| product use in unapproved indicationSignal | 14 | 3.4 | 2.0 | 22 |
| drug ineffectiveSignal | 72 | 3.3 | 2.7 | 120 |
| pyrexiaSignal | 18 | 3.1 | 2.0 | 24 |
| diarrhoeaSignal | 29 | 2.7 | 1.9 | 30 |
| death | 19 | 1.3 | 0.9 | 1 |
| nausea | 17 | 1.3 | 0.8 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.